A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-07-31

Study Completion Date

2009-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An increased prevalence of the metabolic syndrome has been found in patients with systemic lupus erythematosus in recent years.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Metformin In Prevention of Lupus Nephritis

NCT04145687

Lupus Nephritis

UNKNOWN PHASE4

The Effect of Metformin on Reducing Lupus Flares

NCT02741960

Systemic Lupus Erythematosus

COMPLETED PHASE4

Insulin Resistance and Atherosclerosis in Women With Lupus

NCT00544102

Systemic Lupus Erythematosus Insulin Resistance Atherosclerosis

COMPLETED

Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients

NCT04024306

System; Lupus Erythematosus

UNKNOWN

Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus

NCT03179046

Systemic Lupus Erythematosus

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will investigate the prevalence of the metabolic syndrome in patients with SLE in Taiwan. We expect our study will provide further understanding of the association between SLE and metabolic syndrome, which may give direction to prevent late cardiovascular morbidity and mortality in SLE patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Cardiovascular Risk Factors Systemic Lupus Erythematosus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Systemic lupus erythematosus

Patients should fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus

No interventions assigned to this group

Normal control

Age- and sex-matched health volunteers will serve as controls.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persons aged 18 and above.
* Persons fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus in the patient group.